These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26255866)

  • 1. The yin-yang driving urinary tract infection and how proteomics can enhance research, diagnostics, and treatment.
    Floyd KA; Meyer AE; Nelson G; Hadjifrangiskou M
    Proteomics Clin Appl; 2015 Dec; 9(11-12):990-1002. PubMed ID: 26255866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence factors of uropathogenic E. coli and their interaction with the host.
    Lüthje P; Brauner A
    Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.
    Barber AE; Norton JP; Wiles TJ; Mulvey MA
    Microbiol Mol Biol Rev; 2016 Jun; 80(2):351-67. PubMed ID: 26935136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
    Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA
    Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of uropathogenic Escherichia coli outer membrane protein T in pathogenesis of urinary tract infection.
    He XL; Wang Q; Peng L; Qu YR; Puthiyakunnon S; Liu XL; Hui CY; Boddu S; Cao H; Huang SH
    Pathog Dis; 2015 Apr; 73(3):. PubMed ID: 25825479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of uropathogenic Escherichia coli.
    Cash P
    Expert Rev Proteomics; 2014 Feb; 11(1):43-58. PubMed ID: 24393038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Omic' Approaches to Study Uropathogenic Escherichia coli Virulence.
    Lo AW; Moriel DG; Phan MD; Schulz BL; Kidd TJ; Beatson SA; Schembri MA
    Trends Microbiol; 2017 Sep; 25(9):729-740. PubMed ID: 28550944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-specific induction of Escherichia coli fitness genes during human urinary tract infection.
    Subashchandrabose S; Hazen TH; Brumbaugh AR; Himpsl SD; Smith SN; Ernst RD; Rasko DA; Mobley HL
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18327-32. PubMed ID: 25489107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glycobiology of uropathogenic E. coli infection: the sweet and bitter role of sugars in urinary tract immunity.
    Lupo F; Ingersoll MA; Pineda MA
    Immunology; 2021 Sep; 164(1):3-14. PubMed ID: 33763853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the Escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection: contribution to intracellular biofilm development.
    Goller CC; Seed PC
    Virulence; 2010; 1(4):333-7. PubMed ID: 21178466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis.
    Guglietta A
    Future Microbiol; 2017 Mar; 12():239-246. PubMed ID: 28262045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
    Yun KW; Kim HY; Park HK; Kim W; Lim IS
    J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-based profiling of the immune response to uropathogenic Escherichia coli in adult patients immediately following hospital admission for acute cystitis.
    Sundac L; Dando SJ; Sullivan MJ; Derrington P; Gerrard J; Ulett GC
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27354295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-Derived Nitric Oxide and Its Antibacterial Effects in the Urinary Tract.
    Svensson L; Poljakovic M; Demirel I; Sahlberg C; Persson K
    Adv Microb Physiol; 2018; 73():1-62. PubMed ID: 30262107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection.
    Carey AJ; Sullivan MJ; Duell BL; Crossman DK; Chattopadhyay D; Brooks AJ; Tan CK; Crowley M; Sweet MJ; Schembri MA; Ulett GC
    J Infect Dis; 2016 Feb; 213(4):659-68. PubMed ID: 26324782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenomics of uropathogenic Escherichia coli.
    Agarwal J; Srivastava S; Singh M
    Indian J Med Microbiol; 2012; 30(2):141-9. PubMed ID: 22664427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of virulence factors and phylogenetic characterization of uropathogenic Escherichia coli causing urinary tract infection in patients with and without diabetes mellitus.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    Trans R Soc Trop Med Hyg; 2015 Dec; 109(12):769-74. PubMed ID: 26567223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.
    Horvath DJ; Patel AS; Mohamed A; Storm DW; Singh C; Li B; Zhang J; Koff SA; Jayanthi VR; Mason KM; Justice SS
    J Bacteriol; 2016 Jan; 198(6):964-72. PubMed ID: 26755631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.